Diagnostics

Dr. Howard Bailey, a top cancer center leader, joins Cofactor Genomics. It's a strategic bet on RNA's power to finally predict immunotherapy success.

A landmark study validates Astrin Biosciences' proteomic test, Certitude, boasting >92% accuracy and offering new hope for women with dense breasts.

CorVascular's new DuplexABI, developed with Terason, merges two key vascular tests. Can this workflow innovation overcome complex reimbursement hurdles?

A partnership with UTMB to deploy rapid Lassa fever diagnostics in West Africa is more than a public health play; it's a high-stakes field test for the future of portable molecular labs.

Solid Q2 earnings are just the start. Photocure is moving beyond its core imaging tech with key acquisitions and AI partnerships, building a full-spectrum platform.

As Agilent prepares its Q3 report, the numbers are more than finance; they are a key signal for the future of diagnostics and life sciences innovation.

BGLC aims to upend cancer monitoring in emerging markets with a low-cost liquid biopsy. But can a micro-cap execute on this billion-dollar vision?

With labs facing staff shortages and rising demand, SCIEX's new software and hardware promise to speed up critical test results from sample to answer.

Thermo Fisher's latest innovations tackle medicine's toughest challenges, from cancer to preeclampsia, using automation and rapid data to redefine diagnostics.

With a massive global study and powerful data analytics, Seegene aims to prove its new combined HPV/STI test can unmask silent co-infections and set a new standard.

Internal data showing an 82% overlap between HPV and STI cases fuels Seegene's push for a single, comprehensive test, challenging decades of siloed screening.

Waters Corp. has launched a mass spectrometer promising a new era of diagnostic sensitivity. But can its operational robustness overcome the real-world hurdles?

Labcorp's new direct-to-consumer genetic panel promises early risk detection. But does it create a new set of challenges for patients and doctors?

A new partnership between Lilac Biosciences and Soin Neuroscience aims to end the guesswork in pain management with groundbreaking RNA biomarker research.

A new solution from Alps Dx targets the messy, error-prone start of oral fluid testing, signaling a major shift toward automated, reliable diagnostics.

Complex diagnostic devices are vital, but scaling them is a major hurdle. A new blueprint emerges for de-risking the path from prototype to production.

A new pilot by Teal Health and UC Davis Health integrates an FDA-authorized self-collection kit into hospital workflows, targeting overdue patients.

With a mixed Q1 and a promise of a stronger second half, Myriad Genetics' upcoming earnings call will be a crucial test of its strategic health and pipeline.

With fresh capital and key regulatory approvals, Median Technologies is launching its AI lung cancer tool, powered by a stable and record-setting iCRO business.

A new AI-driven test from BRAINBox Solutions combines blood analysis and cognitive data, promising to finally replace guesswork in concussion diagnosis.